Thank You!
We will keep you updated
The latest from Median
Median Technologies today reported its 2025 consolidated annual financial results, and provided key business highlights for the first quarter of 2026.
Median Technologies announces collaboration with Tempus to expand access to eyonis® LCS Software as a Medical Device in the United States
Median Technologies receives FDA 510(k) clearance for eyonis® LCS, the first AI tech-based detection and diagnosis device for lung cancer screening
Median will be exhibiting at the 2026 ASCO Annual Meeting, which will take place from May 29 to June 2 in Chicago, IL. Meet us at McCormick Place South, Hall A, Booth #36102 to learn more about our breakthrough imaging solutions and services for oncology clinical trials.
Visit our team at booth #D07 to learn about our best-in-class central imaging services for oncology clinical trials and how we are leveraging the latest in AI-powered imaging intelligence to develop actionable insights for sponsors worldwide.
Conferences
May 29 to June 2, 2026ASCO 2026
Du 29 mai au 2 Juin, Median participe à la réunion annuelle de l’ASCO qui se tiendra à Chicago. Nous serons heureux de vous retrouver sur notre stand #36102 McCormick Place South, Exhibit Hall A.
Webinars
Using Imaging in Clinical Trials to Improve Data and Decisions
Watch the recording of this webinar to gain actionable insights into building and strategizing imaging in clinical trials to minimize risk, reduce delays and set the stage for smarter trials.